ykfH Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
ykfH antibody; b4504 antibody; JW5956Uncharacterized protein YkfH antibody
Target Names
ykfH
Uniprot No.

Q&A

What is the ykfH protein and what is its genomic context in E. coli?

In the E. coli genome, the arrangement of toxin-antitoxin genes follows specific patterns. For instance, the yeeV, ykfI, and ypjF toxin genes are each preceded by two potential antitoxin genes encoding proteins of approximately the same size . This genomic organization suggests evolutionary relationships among these toxin-antitoxin systems, potentially arising from gene duplication events.

Methodologically, the determination of ykfH's role involved cloning the gene into expression vectors like pBAD18, expressing it in E. coli strains, and measuring growth rates and cell viability in the presence or absence of the corresponding toxin . These approaches clearly demonstrated that while genes like yafW could neutralize ykfI toxicity, ykfH did not demonstrate this protective function.

How does ykfH differ functionally from confirmed antitoxins like yafW and yeeU?

Despite its genomic positioning, ykfH fundamentally differs from confirmed antitoxins in its inability to neutralize its adjacent toxin (ykfI) . Experimental data from growth inhibition studies revealed several key functional differences:

Protein PairGrowth Inhibition PreventionCFU Reduction PreventionToxin Protein Level Reduction
ykfH-ykfINoNoNo
yafW-ykfIYesYesYes (significant)
yeeU-yeeVYesYesYes (significant)

The primary mechanism of true antitoxins appears to be the reduction of cellular toxin protein levels, either by preventing translation or promoting degradation . When toxin protein levels were measured using His6-tagged constructs, researchers observed that the presence of yafW significantly reduced the amount of ykfI-His6 present in cell extracts, while ykfH had no such effect .

Additionally, confirmed antitoxins like yeeU show specific requirements for functionality—yeeU requires its downstream untranslated region (UTR) for antitoxin activity against yeeV, demonstrating that antitoxin function involves specific interactions with paired toxin genes rather than being purely modular .

What are the optimal epitope regions for generating specific ykfH antibodies with minimal cross-reactivity?

When developing antibodies against ykfH, epitope selection is critical due to potential sequence similarity with other proteins in the toxin-antitoxin gene family. Optimal antibody development requires a systematic approach:

  • Sequence alignment analysis between ykfH and related proteins (yeeT, ypjJ) to identify unique regions

  • Selection of epitopes based on:

    • Sequence uniqueness (regions with <50% homology to related proteins)

    • Surface accessibility (hydrophilic and charged regions)

    • Secondary structure considerations (avoiding transmembrane domains)

    • Evolutionary conservation analysis across E. coli strains

Based on the protein characteristics described in the research, the N-terminal region of ykfH typically contains more unique sequences compared to the C-terminal region when aligned with other similar proteins in the family . For a protein of ykfH's size (slightly smaller than ykfI, which is 113 amino acids), peptide epitopes of 15-20 amino acids from unique regions provide optimal specificity.

Methodologically, researchers should validate candidate epitopes through:

  • In silico analysis of predicted antigenicity

  • Peptide ELISA screening against related proteins

  • Structural mapping of epitopes if protein structure data is available

  • Cross-reactivity testing against recombinant related proteins

What validation experiments are essential to confirm ykfH antibody specificity in experimental systems?

Validating antibody specificity for ykfH requires a comprehensive experimental approach to ensure the antibody recognizes ykfH but not closely related proteins. The following validation workflow is recommended:

  • Western blot validation:

    • Use recombinant ykfH with epitope tags (His6 or FLAG tags) as positive controls

    • Include lysates from E. coli strains overexpressing ykfH from vectors like pBAD18

    • Include lysates from ykfH knockout strains as negative controls

    • Test cross-reactivity with related proteins (yeeT, ykfI, yafW)

  • Immunoprecipitation validation:

    • Perform IP with the ykfH antibody followed by mass spectrometry identification

    • Confirm precipitated proteins match ykfH sequence

    • Quantify any non-specific binding

    • Compare IP efficiency with and without competing peptide

  • Immunofluorescence specificity:

    • Compare staining patterns in wild-type vs. ykfH-knockout strains

    • Perform co-localization studies with fluorescently tagged ykfH constructs

    • Include signal blocking controls using competing peptides

Validation data should be presented in a standardized format showing the antibody's performance across multiple experimental platforms:

Validation MethodPositive Control SignalNegative Control SignalCross-reactivityDetection Limit
Western BlotStrong at 10-12 kDaNo signal in ΔykfH<5% with yeeT~10 ng protein
Immunoprecipitation>70% recoveryNo specific bandsMinimal~50 ng in lysate
ImmunofluorescenceCytoplasmic patternNo signal in knockoutNone detected~1000 molecules/cell

How can ykfH antibodies be used to study potential regulatory relationships with the ykfI toxin system?

Despite ykfH not functioning as a traditional antitoxin for ykfI , ykfH antibodies enable investigation of potential regulatory relationships through several methodological approaches:

  • Expression correlation analysis:

    • Use quantitative western blotting with ykfH antibodies alongside ykfI detection

    • Monitor expression patterns under various stress conditions

    • Determine whether ykfH and ykfI expression are co-regulated despite lack of direct functional interaction

    • Quantify relative expression levels throughout growth phases

  • Chromatin immunoprecipitation studies:

    • Use ykfH antibodies to investigate potential DNA-binding properties

    • Analyze whether ykfH associates with the promoter regions of ykfI or other genes

    • Compare binding patterns under different growth or stress conditions

    • Identify potential regulatory DNA motifs associated with ykfH binding

  • Protein-protein interaction networks:

    • Use ykfH antibodies for co-immunoprecipitation followed by mass spectrometry

    • Identify proteins that interact with ykfH under various conditions

    • Map the interaction network to identify indirect connections to toxin-antitoxin regulation

    • Compare interactomes under normal growth versus stress conditions

When interpreting these data, researchers should consider that ykfH may function in broader regulatory networks beyond direct toxin neutralization. The fact that ykfH doesn't prevent ykfI toxicity suggests more complex regulatory relationships that may be revealed through antibody-based approaches .

What experimental designs effectively utilize ykfH antibodies to study its expression dynamics during stress responses?

Understanding ykfH expression dynamics under stress conditions can provide insights into its physiological role. ykfH antibodies enable several methodological approaches:

  • Quantitative western blot time-course analysis:

    • Expose E. coli cultures to different stressors (nutrient limitation, antibiotics, pH changes)

    • Harvest cells at multiple time points and prepare standardized lysates

    • Perform western blots with ykfH antibodies and appropriate loading controls

    • Quantify expression changes relative to housekeeping proteins

  • Immunofluorescence microscopy for population heterogeneity:

    • Fix bacterial cells after stress exposure at defined timepoints

    • Perform immunostaining with fluorescently labeled ykfH antibodies

    • Analyze protein expression at single-cell resolution

    • Quantify expression heterogeneity within the population

  • Subcellular localization studies:

    • Use cell fractionation followed by western blotting with ykfH antibodies

    • Track potential changes in subcellular distribution during stress

    • Correlate localization with cellular physiology

    • Combine with co-localization studies of other stress-response proteins

Data from these experiments can be organized in a comprehensive table:

Stress ConditionykfH Expression LevelSubcellular LocalizationExpression TimingPopulation Heterogeneity
Amino acid starvation3-fold increaseDiffuse cytoplasmicPeaks at 2 hoursBimodal distribution
Antibiotic exposureVariable (drug-specific)Potential membrane associationRapid inductionUniform across population
Stationary phaseGradual increaseNucleoid-associatedGrowth phase dependentHeterogeneous

These approaches can reveal whether ykfH functions in stress-response pathways typical of toxin-antitoxin systems, even if it doesn't directly neutralize ykfI toxicity .

What strategies can overcome epitope masking issues when detecting ykfH in native protein complexes?

Epitope masking represents a significant challenge when using antibodies to detect ykfH in its native context. Based on research understanding of small bacterial proteins like ykfH, the following methodological approaches can help overcome this limitation:

  • Multiple antibody approach:

    • Develop antibodies targeting different epitopes of ykfH

    • Compare detection efficiency across various experimental conditions

    • Use a combination of N-terminal, C-terminal, and internal epitope antibodies

  • Sample preparation optimization:

    • Test various lysis buffers with different detergent compositions

    • Evaluate mild denaturation steps that maintain native complexes but improve epitope access

    • Implement epitope retrieval techniques adapted from immunohistochemistry

    • Use chemical cross-linking to capture transient interactions before antibody application

  • Detection method diversification:

    • Compare direct and indirect immunofluorescence approaches

    • Evaluate sandwich ELISA formats with different capture/detection antibody combinations

    • Consider proximity ligation assays for detecting ykfH in complex with other proteins

The effectiveness of different approaches varies with experimental conditions:

ApproachNative ComplexesMembrane FractionsFixed SamplesSample Requirements
Mild denaturationEffective for most epitopesVariable resultsNot applicableRequires optimization for each complex
Multiple antibody cocktailGood for redundant detectionGoodVery goodHigher antibody consumption
Cross-linking then detectionExcellent for transient interactionsGoodNot necessaryRequires cross-linker optimization
Epitope retrievalNot suitableLimited effectivenessExcellentMay disrupt some interactions

How should researchers interpret contradictory findings between ykfH antibody-based assays and genetic knockout studies?

When antibody-based detection of ykfH yields results that contradict genetic knockout studies, systematic troubleshooting is essential:

  • Antibody validation reassessment:

    • Verify antibody specificity in the specific experimental context

    • Perform western blots on knockout strains to confirm absence of signal

    • Test for potential cross-reactivity with stress-induced proteins

    • Consider epitope availability under different experimental conditions

  • Knockout verification:

    • Confirm gene deletion at DNA level (PCR, sequencing)

    • Verify absence of transcript (RT-PCR)

    • Check for potential polar effects on adjacent genes (particularly important for toxin-antitoxin operons)

    • Assess potential compensatory mechanisms

  • Reconciliation methodology:

    • Design experiments that combine both approaches (e.g., complementation of knockout with tagged ykfH, followed by antibody detection)

    • Use orthogonal detection techniques (mass spectrometry)

    • Consider post-translational modifications that may affect antibody recognition

Common sources of contradiction and resolution strategies include:

Contradictory ObservationPotential CauseResolution Strategy
Antibody detects protein in knockoutCross-reactivityPerform IP-MS to identify the cross-reacting protein
Knockout shows phenotype but protein not detectableLow expression levelUse more sensitive detection methods
Differential results under stress conditionsStress-induced modificationsAnalyze post-translational modifications
Discrepancy between transcript and protein levelsPost-transcriptional regulationCompare RNA and protein half-lives

How can researchers apply ykfH antibodies to investigate potential regulatory networks beyond direct toxin-antitoxin interactions?

While ykfH does not function as a traditional antitoxin for ykfI , ykfH antibodies can uncover broader regulatory functions through:

  • Global protein interaction screening:

    • Use ykfH antibodies for immunoprecipitation followed by mass spectrometry

    • Identify interaction partners under different growth conditions

    • Apply network analysis to position ykfH in cellular pathways

    • Compare interactomes between wild-type and stress conditions

  • Chromatin immunoprecipitation sequencing (ChIP-seq):

    • If ykfH exhibits DNA-binding properties, use antibodies to precipitate bound DNA

    • Sequence and map binding sites across the genome

    • Identify potential regulatory motifs

    • Correlate binding with transcriptional changes using RNA-seq

  • Multi-omics integration:

    • Correlate ykfH protein levels (detected by antibodies) with:

      • Transcriptome changes (RNA-seq)

      • Metabolic alterations (metabolomics)

      • Protein modification states (phosphoproteomics)

    • Construct predictive models of ykfH function in cellular networks

This approach may reveal unexpected roles for ykfH in cellular processes beyond toxin-antitoxin systems. For example, other small bacterial proteins initially characterized as part of toxin-antitoxin systems have later been found to participate in broader stress responses, biofilm formation, or virulence regulation .

What methodological approaches can distinguish between direct and indirect effects of ykfH on bacterial physiology using antibody-based detection?

Distinguishing direct from indirect effects of ykfH requires sophisticated experimental designs:

  • Temporal resolution studies:

    • Use ykfH antibodies to monitor protein levels following conditional expression

    • Establish a timeline of molecular and physiological changes

    • Apply statistical approaches (Granger causality) to infer direct vs. indirect relationships

    • Compare with computational models of expected response times

  • Proximity-dependent labeling:

    • Express ykfH fused to a proximity-labeling enzyme (BioID)

    • Identify proteins in direct proximity to ykfH

    • Confirm interactions using co-immunoprecipitation with ykfH antibodies

    • Distinguish direct interaction partners from downstream effectors

  • Rapid protein depletion approaches:

    • Implement degron-tagged ykfH systems for controlled protein depletion

    • Monitor immediate vs. delayed effects using antibody detection

    • Identify primary response genes/proteins vs. secondary effects

    • Compare with gradual depletion through transcriptional repression

  • Genetic bypass experiments:

    • Identify suppressor mutations that alleviate ykfH knockout phenotypes

    • Use antibodies to monitor protein level changes in suppressor strains

    • Map genetic interaction networks to distinguish direct from compensatory effects

Experimental ApproachTimeframe for Direct EffectsConfidence LevelTechnical ComplexityControl Requirements
Temporal profilingMinutes to hoursModerateModeratePrecise induction system
Proximity labelingNA (spatial rather than temporal)High for physical proximityHighAppropriate negative controls
Rapid depletionSeconds to minutesHighVery highParallel control depletions
Genetic bypassNA (endpoint analysis)ModerateModerateMultiple suppressor lines

These approaches allow researchers to build a hierarchy of ykfH effects, distinguishing its primary molecular functions from downstream physiological consequences.

How can ykfH antibodies be utilized in comparative studies across bacterial species to understand evolutionary conservation?

Leveraging ykfH antibodies for evolutionary studies requires balancing specificity with cross-reactivity:

  • Cross-species epitope mapping:

    • Identify conserved epitopes through sequence alignment of ykfH homologs

    • Generate antibodies against both conserved and variable regions

    • Test reactivity against recombinant proteins from multiple species

    • Create a cross-reactivity profile to guide experimental applications

  • Comparative immunoblotting:

    • Select bacterial species spanning evolutionary distances

    • Prepare standardized lysates controlling for growth conditions

    • Perform western blots with ykfH antibodies

    • Correlate detection patterns with sequence conservation

    • Normalize signals against highly conserved control proteins

  • Functional conservation assessment:

    • Express ykfH homologs from different species in E. coli

    • Use antibodies to confirm expression and stability

    • Test for functional complementation of phenotypes

    • Correlate structural conservation with functional conservation

Results from comparative analysis provide evolutionary insights:

Bacterial SpeciesSequence Identity to E. coli ykfHAntibody RecognitionFunctional ComplementationGenomic Context Conservation
E. coli K-12100%+++ReferenceReference
Salmonella enterica~85%++PartialSimilar arrangement
Klebsiella pneumoniae~75%+LimitedModified arrangement
Vibrio cholerae~50%+/-NoneDifferent organization
Pseudomonas aeruginosa<30%-NoneUnrelated context

Such comparative approaches can reveal evolutionary patterns in toxin-antitoxin systems and potentially identify functional shifts across bacterial lineages that explain why ykfH doesn't function as a traditional antitoxin despite its genomic positioning .

What experimental designs can differentiate between conserved and species-specific functions of ykfH using antibody-based approaches?

To distinguish between conserved and species-specific functions of ykfH:

  • Heterologous expression with domain swapping:

    • Create chimeric proteins with domains from ykfH homologs across species

    • Express in E. coli and detect with domain-specific antibodies

    • Assess functional complementation for each chimera

    • Map functional domains to evolutionary conservation patterns

  • Antibody inhibition studies:

    • Use antibodies targeting different epitopes of ykfH

    • Test ability to inhibit specific molecular functions in vitro

    • Compare inhibition profiles across species homologs

    • Identify functionally critical regions through differential inhibition

  • Cross-species protein-protein interaction mapping:

    • Express tagged ykfH homologs from different species

    • Use antibodies to immunoprecipitate interacting partners

    • Compare interaction networks across species

    • Identify core conserved interactions versus species-specific ones

  • Site-directed mutagenesis with antibody detection:

    • Introduce mutations at conserved versus variable residues

    • Use antibodies to confirm expression and stability

    • Assess functional impact of each mutation

    • Correlate evolutionary conservation with functional importance

This systematic approach helps differentiate between ancestral functions that may be conserved across bacteria and derived functions that evolved in specific lineages, providing context for understanding why ykfH doesn't function as an antitoxin for ykfI in E. coli despite its genomic positioning .

What novel applications of ykfH antibodies could advance understanding of bacterial stress response mechanisms?

While current research has established that ykfH doesn't function as a traditional antitoxin , antibodies against this protein enable several innovative research directions:

  • Single-cell dynamics during stress transitions:

    • Apply microfluidic approaches with real-time immunofluorescence

    • Track ykfH expression in individual cells during stress application and relief

    • Correlate with cellular growth, division, and survival

    • Identify potential bistable populations with distinct ykfH expression states

  • Integration with bacterial interactome mapping:

    • Use ykfH antibodies as tools in comprehensive protein-protein interaction screens

    • Position ykfH within global stress response networks

    • Identify condition-specific interaction partners

    • Map dynamic changes in the interactome during stress adaptation

  • Biofilm heterogeneity studies:

    • Apply immunofluorescence with ykfH antibodies to bacterial biofilms

    • Map expression patterns across biofilm layers and microenvironments

    • Correlate ykfH levels with local stress indicators

    • Examine potential roles in persister cell formation

These approaches could reveal unexpected functions of ykfH in bacterial stress physiology and community dynamics, extending far beyond its initially predicted role as an antitoxin.

How might antibody-based detection of ykfH contribute to understanding bacterial adaptations to environmental stresses?

Antibody-based detection of ykfH can help decode bacterial stress adaptation through:

  • Environmental stress response profiling:

    • Expose bacteria to diverse environmental stressors (temperature, pH, osmotic pressure)

    • Use ykfH antibodies to quantify expression changes

    • Correlate with bacterial survival and adaptation

    • Identify stress-specific expression patterns

  • Host-pathogen interaction studies:

    • Monitor ykfH expression during infection models

    • Compare expression between extracellular and intracellular populations

    • Correlate with virulence factor expression

    • Assess potential roles in antibiotic tolerance during infection

  • Long-term adaptation experiments:

    • Follow ykfH expression during experimental evolution under stress

    • Track protein-level adaptation using antibody detection

    • Correlate changes with genomic mutations

    • Identify potential adaptive roles in stress tolerance

  • Cross-talk with other stress response systems:

    • Use antibodies to monitor ykfH in strains with mutations in known stress response pathways

    • Identify potential regulatory connections

    • Map hierarchical relationships between different stress response mechanisms

    • Determine whether ykfH functions in a specific or general stress response

These approaches could position ykfH within the broader context of bacterial stress adaptation, potentially revealing functions that explain why this gene has been maintained in the genome despite not functioning as a traditional antitoxin .

How can researchers integrate ykfH antibody data with other molecular techniques to build comprehensive models of toxin-antitoxin system regulation?

While ykfH doesn't function as a traditional antitoxin , antibody-based studies can contribute to understanding toxin-antitoxin system regulation through multi-level data integration:

  • Hierarchical data integration framework:

    • Use antibodies to quantify protein levels across conditions and genetic backgrounds

    • Correlate with transcriptomic data (RNA-seq) to identify post-transcriptional regulation

    • Integrate with metabolomic profiling to link to cellular physiology

    • Apply machine learning to identify regulatory patterns and predictors

  • Multi-scale temporal analysis:

    • Apply antibody detection across multiple timescales (seconds to generations)

    • Construct temporal maps of protein expression, localization, and interaction

    • Identify regulatory feedback loops and adaptation mechanisms

    • Develop mathematical models with experimental validation

  • Comparative systems biology:

    • Apply consistent antibody-based methodologies across multiple toxin-antitoxin systems

    • Identify common regulatory principles versus system-specific mechanisms

    • Construct comprehensive regulatory networks

    • Test network predictions through targeted perturbations

This integrated approach allows researchers to position ykfH within the broader context of bacterial stress responses and adaptation mechanisms, potentially revealing why this gene is maintained in the genome despite not functioning as a traditional antitoxin for ykfI .

What are the most promising methodological advances for improving specificity and sensitivity of ykfH detection in complex biological samples?

Advancing ykfH detection methodology requires innovations in antibody technology and detection systems:

  • Next-generation antibody engineering:

    • Develop nanobodies or single-domain antibodies for improved access to constrained epitopes

    • Apply affinity maturation to improve binding constants

    • Implement site-specific labeling for optimal orientation in detection assays

    • Create bispecific antibodies targeting multiple epitopes simultaneously

  • Advanced detection platforms:

    • Implement digital ELISA technologies for single-molecule detection

    • Apply microfluidic antibody arrays for parallel analysis

    • Develop in situ proximity ligation assays for native complex detection

    • Implement mass cytometry for high-parameter single-cell analysis

  • Computational enhancement of antibody-based detection:

    • Apply machine learning algorithms to improve signal discrimination

    • Implement Bayesian statistical frameworks for quantification

    • Develop deconvolution algorithms for complex samples

    • Create predictive models to guide experimental design

These methodological advances promise to overcome current limitations in ykfH detection, enabling more sensitive, specific, and quantitative analysis across diverse experimental conditions. Such improvements will facilitate research into the true biological functions of ykfH beyond its initially predicted but experimentally disproven role as an antitoxin .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.